↓ Skip to main content

Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study?

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, August 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (63rd percentile)
  • Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

twitter
2 X users
patent
1 patent

Citations

dimensions_citation
172 Dimensions

Readers on

mendeley
141 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study?
Published in
Journal of Experimental & Clinical Cancer Research, August 2019
DOI 10.1186/s13046-019-1362-1
Pubmed ID
Authors

Fengzhi Li, Ieman Aljahdali, Xiang Ling

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 141 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 141 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 29 21%
Student > Ph. D. Student 19 13%
Student > Master 14 10%
Student > Bachelor 13 9%
Student > Doctoral Student 8 6%
Other 12 9%
Unknown 46 33%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 34 24%
Medicine and Dentistry 18 13%
Chemistry 13 9%
Agricultural and Biological Sciences 9 6%
Pharmacology, Toxicology and Pharmaceutical Science 5 4%
Other 14 10%
Unknown 48 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 September 2021.
All research outputs
#7,783,733
of 25,385,509 outputs
Outputs from Journal of Experimental & Clinical Cancer Research
#478
of 2,382 outputs
Outputs of similar age
#127,788
of 351,800 outputs
Outputs of similar age from Journal of Experimental & Clinical Cancer Research
#16
of 62 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 2,382 research outputs from this source. They receive a mean Attention Score of 4.8. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 351,800 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.
We're also able to compare this research output to 62 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.